Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint-Reference-Cited by-同舟云学术

Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint

Published:2001-04 Issue:5 Volume:49 Page:1287-1296
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Perez Carlos A,Michalski Jeff M,Lockett Mary Ann

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference56 articles.

1. Prostate;Perez,1998

2. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3);Perez;Cancer,1993

3. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate;Bishoff;Urology,1995

4. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

5. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy;Oesterling;J Urol,1988

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical control of prostate cancer with iodine-125 brachytherapy alone: experience from a single institution;Clinical and Translational Oncology;2012-05

2. A Review on the Clinical Utility of PSA in Cancer Prostate;Indian Journal of Surgical Oncology;2012-03-03

3. Effect of Whole Pelvic Radiotherapy for Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Long-Term Androgen Deprivation Therapy;International Journal of Radiation Oncology*Biology*Physics;2011-12

4. Lokales Prostatakarzinomrezidiv nach Strahlentherapie;Der Urologe;2010-03-18

5. Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer;The Prostate;2009-12-30